Key facts
- It has raised $630K; the latest was Seed Round ($630K) in Nov 2025.
- Notable investors include Greiner Innoventures, The Better Fund.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Muun Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Muun Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Muun Health
Developer of biosensor system components designed for hormone monitoring purposes. The company's platform incorporates bioselective elements optimized for detecting hormonal levels in interstitial fluid, integrating component development, testing, and demonstration workflows to support precision diagnostics, enabling healthcare providers and researchers improved access to real-time biochemical data for clinical and investigational applications
- Sector
- Healthcare
- HQ
- Estonia
- Founded
- 2023
- Website
- muunhealth.com/
- Ownership
- Privately Held (backing)
Muun Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Muun Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Muun Health in its N-PORT filings yet. We sweep new filings monthly.